ATE382620T1 - Pyrano, piperidino, und thiopyrano derivate und methode zur verwendung - Google Patents
Pyrano, piperidino, und thiopyrano derivate und methode zur verwendungInfo
- Publication number
- ATE382620T1 ATE382620T1 AT99960168T AT99960168T ATE382620T1 AT E382620 T1 ATE382620 T1 AT E382620T1 AT 99960168 T AT99960168 T AT 99960168T AT 99960168 T AT99960168 T AT 99960168T AT E382620 T1 ATE382620 T1 AT E382620T1
- Authority
- AT
- Austria
- Prior art keywords
- thiopyrano
- pyrano
- piperidino
- derivatives
- hyperpolarizing
- Prior art date
Links
- KZKRRZFCAYOXQE-UHFFFAOYSA-N 1$l^{2}-azinane Chemical class C1CC[N]CC1 KZKRRZFCAYOXQE-UHFFFAOYSA-N 0.000 title 1
- 102000004257 Potassium Channel Human genes 0.000 abstract 1
- 210000000170 cell membrane Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000008602 contraction Effects 0.000 abstract 1
- 230000002102 hyperpolarization Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 108020001213 potassium channel Proteins 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
- C07C45/298—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with manganese derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18169098A | 1998-10-28 | 1998-10-28 | |
| US09/421,862 US6191140B1 (en) | 1998-10-28 | 1999-10-20 | Pyrano, piperidino, and thiopyrano compounds and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382620T1 true ATE382620T1 (de) | 2008-01-15 |
Family
ID=26877422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99960168T ATE382620T1 (de) | 1998-10-28 | 1999-10-28 | Pyrano, piperidino, und thiopyrano derivate und methode zur verwendung |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6191140B1 (de) |
| EP (1) | EP1124828B1 (de) |
| JP (1) | JP2002528454A (de) |
| KR (1) | KR20010085975A (de) |
| CN (1) | CN1335846A (de) |
| AT (1) | ATE382620T1 (de) |
| AU (1) | AU764163B2 (de) |
| BG (1) | BG105524A (de) |
| BR (1) | BR9914688A (de) |
| CA (1) | CA2348576A1 (de) |
| CZ (1) | CZ20011480A3 (de) |
| DE (1) | DE69937895T2 (de) |
| ES (1) | ES2299272T3 (de) |
| HK (1) | HK1041877A1 (de) |
| HU (1) | HUP0104146A3 (de) |
| NO (1) | NO318628B1 (de) |
| NZ (1) | NZ511041A (de) |
| PL (1) | PL347552A1 (de) |
| SK (1) | SK5242001A3 (de) |
| TR (1) | TR200101140T2 (de) |
| WO (1) | WO2000024743A1 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6593335B1 (en) * | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
| US6265417B1 (en) | 1997-12-18 | 2001-07-24 | Abbott Laboratories | Potassium channel openers |
| US6642222B2 (en) * | 1998-10-28 | 2003-11-04 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| WO2001009096A2 (en) * | 1999-08-03 | 2001-02-08 | Abbott Laboratories | Potassium channel openers |
| US6538004B2 (en) * | 2000-03-03 | 2003-03-25 | Abbott Laboratories | Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| DE60131660D1 (de) | 2000-08-02 | 2008-01-10 | Astrazeneca Ab | Verfahren zur asymetrischen synthese von substituierten 1,4-dihydropyridin-derivaten |
| WO2003011869A1 (en) * | 2001-07-30 | 2003-02-13 | Abbott Laboratories | Radioligands and their use for identifying potassium channel modulators |
| US6632418B2 (en) * | 2001-07-30 | 2003-10-14 | Abbott Laboratories | Radioligands and their use for identifying potassium channel modulators |
| US20030153773A1 (en) * | 2002-02-14 | 2003-08-14 | Wayne Gregory S. | Process for the production of dihydropyridines |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2093834B (en) | 1981-02-27 | 1984-08-15 | American Home Prod | Antihypertensive agents |
| US4321384A (en) | 1981-02-27 | 1982-03-23 | American Home Products Corporation | Antihypertensive agents |
| US4551534A (en) | 1984-03-30 | 1985-11-05 | American Home Products Corporation | Aralkyl or aryloxyalkyl 1,7-naphthyridine-3-carboxylic acid esters |
| US4618678A (en) | 1985-07-29 | 1986-10-21 | American Home Products Corporation | 4-(2,3-dichloro-6-fluorophenyl)-1,4,5,6,7,8-hexahydro-2-methyl-5-oxo-1,7-naphthyridine-3-carboxylic acid 2-(2,3-dichlorophenoxy)ethyl ester |
| AU6042686A (en) | 1985-07-29 | 1987-02-05 | American Home Products Corporation | 1,4,5,6,7,8-hexahydro-(substituted) phenyl-1,7- napthyridine-3-carboxylic acid derivatives |
| US4596873A (en) | 1985-07-29 | 1986-06-24 | American Home Products Corporation | 1,4,5,6,7,8-Hexahydro-2-alkyl-4-aryl-5-oxo-1,7-naphthyridine-3-carboxylic acid aromatic esters and pharmaceutically acceptable acid addition salts thereof useful as antihypertensive agents |
| EP0539154B1 (de) | 1991-10-21 | 1997-12-29 | Zeneca Limited | Acridine-1,8-Dionderivate als therapeutisches Mittel |
| GB9220570D0 (en) * | 1991-10-21 | 1992-11-11 | Ici Plc | Therapeutic agent |
| GB9318935D0 (en) * | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
| DE4424678A1 (de) * | 1994-07-13 | 1996-01-18 | Bayer Ag | Dioxo-thiopyrano-pyridin-carbonsäure-derivate |
| US6593335B1 (en) * | 1997-12-18 | 2003-07-15 | Abbott Laboratories | Potassium channel openers |
| CN1158259C (zh) * | 1997-12-18 | 2004-07-21 | 艾博特公司 | 钾通道疏通剂 |
| AU1459500A (en) * | 1998-10-28 | 2000-05-15 | Abbott Laboratories | Dihydropyridine compounds and methods of use |
-
1999
- 1999-10-20 US US09/421,862 patent/US6191140B1/en not_active Expired - Fee Related
- 1999-10-28 SK SK524-2001A patent/SK5242001A3/sk unknown
- 1999-10-28 DE DE69937895T patent/DE69937895T2/de not_active Expired - Lifetime
- 1999-10-28 HK HK02101208.4A patent/HK1041877A1/zh unknown
- 1999-10-28 NZ NZ511041A patent/NZ511041A/xx unknown
- 1999-10-28 ES ES99960168T patent/ES2299272T3/es not_active Expired - Lifetime
- 1999-10-28 BR BR9914688-6A patent/BR9914688A/pt not_active IP Right Cessation
- 1999-10-28 CZ CZ20011480A patent/CZ20011480A3/cs unknown
- 1999-10-28 AT AT99960168T patent/ATE382620T1/de not_active IP Right Cessation
- 1999-10-28 TR TR2001/01140T patent/TR200101140T2/xx unknown
- 1999-10-28 WO PCT/US1999/025373 patent/WO2000024743A1/en not_active Ceased
- 1999-10-28 JP JP2000578313A patent/JP2002528454A/ja active Pending
- 1999-10-28 HU HU0104146A patent/HUP0104146A3/hu unknown
- 1999-10-28 EP EP99960168A patent/EP1124828B1/de not_active Expired - Lifetime
- 1999-10-28 CA CA002348576A patent/CA2348576A1/en not_active Abandoned
- 1999-10-28 PL PL99347552A patent/PL347552A1/xx not_active Application Discontinuation
- 1999-10-28 AU AU17095/00A patent/AU764163B2/en not_active Ceased
- 1999-10-28 CN CN99815020A patent/CN1335846A/zh active Pending
- 1999-10-28 KR KR1020017005347A patent/KR20010085975A/ko not_active Ceased
-
2001
- 2001-04-27 NO NO20012100A patent/NO318628B1/no not_active IP Right Cessation
- 2001-05-19 BG BG105524A patent/BG105524A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9914688A (pt) | 2001-10-02 |
| DE69937895D1 (de) | 2008-02-14 |
| EP1124828B1 (de) | 2008-01-02 |
| HUP0104146A3 (en) | 2002-10-28 |
| NO318628B1 (no) | 2005-04-18 |
| KR20010085975A (ko) | 2001-09-07 |
| DE69937895T2 (de) | 2009-01-02 |
| WO2000024743A1 (en) | 2000-05-04 |
| SK5242001A3 (en) | 2001-12-03 |
| HK1041877A1 (zh) | 2002-07-26 |
| EP1124828A1 (de) | 2001-08-22 |
| CZ20011480A3 (cs) | 2001-08-15 |
| US6191140B1 (en) | 2001-02-20 |
| NO20012100D0 (no) | 2001-04-27 |
| AU764163B2 (en) | 2003-08-14 |
| BG105524A (bg) | 2001-12-29 |
| CN1335846A (zh) | 2002-02-13 |
| ES2299272T3 (es) | 2008-05-16 |
| CA2348576A1 (en) | 2000-05-04 |
| PL347552A1 (en) | 2002-04-08 |
| AU1709500A (en) | 2000-05-15 |
| NO20012100L (no) | 2001-06-14 |
| NZ511041A (en) | 2003-03-28 |
| JP2002528454A (ja) | 2002-09-03 |
| HUP0104146A2 (hu) | 2002-04-29 |
| TR200101140T2 (tr) | 2002-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9900100D0 (sv) | New compounds | |
| EE200200710A (et) | Asendatud bitsüklilised derivaadid ebanormaalse rakukasvu raviks | |
| DE59902958D1 (de) | Lithium-bisoxalatoborat, herstellung und verwendung als leitsalz | |
| AU5624699A (en) | Use of 5ht-6 antagonists | |
| DE60118975D1 (de) | Tetrahydropyridinderivate, deren herstellung und deren verwendung als inhibitoren der zellproliferation | |
| PT1242060E (pt) | Tratamento da doenca metastatica | |
| BRPI0410871A (pt) | 3-aminometil-pirrolidinas como bloqueadores do canal de cálcio do tipo n | |
| CY1108808T1 (el) | Ενωσεις μοτιλιδης | |
| ATE382620T1 (de) | Pyrano, piperidino, und thiopyrano derivate und methode zur verwendung | |
| DE60043321D1 (de) | Luziferase Expressionskassetten und Methoden zu ihrer Verwendung | |
| ATE386742T1 (de) | Imidazonaphthyridine | |
| ATE357469T1 (de) | Sterilisierende polymere und deren herstellung und verwendung | |
| PT1278747E (pt) | Compostos de pirano,piperidino e tiopirano e métodos de utilização | |
| ATA7322000A (de) | Verwendung von sekundärem zellwandpolymer prokaryontischer mikroorganismen | |
| ATE381568T1 (de) | Pyrano(2,3-c)imidazo(1,2-a)pyridin-derivate zur behandlung von gastrointestinalen erkrankungen | |
| TR199901416T2 (xx) | Heterosiklik karbonikasit t�revleri. | |
| ATE218138T1 (de) | N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung | |
| WO2003076588A8 (en) | Multiplexed cell transfection using coded carriers | |
| ATE389014T1 (de) | Phosphorylierte glyoxalase i und deren verwendung | |
| AR021502A1 (es) | Uso de derivados de azabicicloalcanos n-sustituidos para el tratamiento de enfermedades del sistema central nervioso | |
| IS8034A (is) | Imídasó[4,5-B]kínólínafleiður og notkun þeirra sem NO-myndunarhemla | |
| WO2003027145A1 (fr) | Inducteur de mort cellulaire, cellules et animaux exprimant cet inducteur, et procede de criblage de medicament anti-mort cellulaire | |
| ATE376993T1 (de) | Herstellung von 3,5,7ö-1h-imidazo 1,5-aöimidazol-2(3h)-on-verb ndungen | |
| TR200100476T2 (tr) | N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları. | |
| ATE275584T1 (de) | Verwendung von sekundärem zellwandpolymer prokaryontischer mikroorganismen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |